Repligen | RGEN - Market Capitalization

Stock Price
134.67
Daily Change
-0.73 -0.54%
Monthly
-17.55%
Yearly
-16.60%
Q1 Forecast
131.47

Repligen reported $7.55B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
Align Technology USD 12.04B 838M Feb/2026
Bio Techne USD 10.78B 1.62B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Bruker USD 5.69B 1.47B Feb/2026
Charles River Laboratories USD 8.08B 1.94B Feb/2026
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.53B 633M Sep/2025
Exact Sciences USD 10.36B 334M Sep/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Henry Schein USD 11.28B 2.31B Feb/2026
Illumina USD 21.21B 588M Feb/2026
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Mettler Toledo International USD 29.7B 1.22B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
OraSure Technologies USD 435M 68M Sep/2023
Pacific Biosciences Of California USD 2.62B 532M Dec/2023
Pfizer USD 152.89B 11.32B Feb/2026
Repligen USD 7.55B 30M Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Standard Biotools USD 521M 24M Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Waters USD 19.14B 3.47B Feb/2026
West Pharmaceutical Services USD 17.83B 1.96B Feb/2026